Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $22.1000 (-4.74%) ($21.2000 - $23.7000) on Thu. Nov. 9, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.66% (three month average) | RSI | 49 | Latest Price | $22.1000(-4.74%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CAPR declines -2.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) ARKK(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.83% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-8%) SLV(-7%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.83% (StdDev 11.66%) | Hourly BBV | 0 () | Intraday Trend | -2.6% | | | |
|
1 - 5 Day Possible Target | $10.96(-50.41%) | Resistance Level | $23.15 | 5 Day Moving Average | $21.8(1.38%) | 10 Day Moving Average | $22.66(-2.47%) | 20 Day Moving Average | $23.15(-4.54%) | To recent high | -35.9% | To recent low | 127.8% | Market Cap | $435m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |